SREBF and miR33 in cholesterol and lipid homeostasis

about

SREBF and miR33 in cholesterol and lipid homeostasis

Item

http://www.wikidata.org/entity/Q30230779

description

This pathway describes transcr ...... a seminar by Dr. Anders Näär.

@en

name

SREBF and miR33 in cholesterol and lipid homeostasis

@en

type

Item

label

SREBF and miR33 in cholesterol and lipid homeostasis

@en

prefLabel

SREBF and miR33 in cholesterol and lipid homeostasis

@en

P1476

SREBF and miR33 in cholesterol and lipid homeostasis

@en

P2093

Kristina Hanspers

http://www.w3.org/2001/XMLSchema#string

Linda Rieswijk

http://www.w3.org/2001/XMLSchema#string

Martina Kutmon

http://www.w3.org/2001/XMLSchema#string

Samuel Sklar

http://www.w3.org/2001/XMLSchema#string

P2410

WP2011

http://www.w3.org/2001/XMLSchema#string

P2860

An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1

P2888

WP2011

P31

biological pathway

P50

Martina Summer-Kutmon

P527

P703

Homo sapiens